IEEE 2621.3-2022 /UL 2621-3-2022 is a technical standard focused on wireless diabetes device security, with particular attention to the use of mobile devices in diabetes control contexts. It is relevant where mobile apps, connected controllers, and communication links interact with diabetes management equipment. This standard helps define a clearer security baseline for design, evaluation, and procurement, supporting safer and more consistent connected-care implementations.

IEEE 2621.3-2022 /UL 2621-3-2022 overview

This standard addresses the security considerations involved when mobile devices are used alongside wireless diabetes systems. In practice, that includes communication between consumer or dedicated mobile platforms and diabetes-control equipment, where data exchange, access control, and system behavior may affect patient use. IEEE 2621.3-2022 /UL 2621-3-2022 is therefore useful for teams that need a structured reference for evaluating security-related functions in a connected medical context, especially where wireless interaction is part of the control workflow.

Typical use cases

Typical use cases include diabetes management solutions that rely on a smartphone or tablet to monitor, configure, or support device operation. It may also apply to wireless patient interfaces, companion applications, and connected control systems used in clinical or home settings. Manufacturers, integrators, and testers can use IEEE 2621.3-2022 /UL 2621-3-2022 when assessing how mobile access fits into a diabetes workflow, particularly where communications security, device pairing, and control reliability are important.

Why this standard matters

This standard matters because wireless diabetes systems depend on dependable communication and controlled access to function safely. Clear security expectations can help reduce implementation inconsistency, support testing and verification, and improve confidence in how mobile devices interact with diabetes-control equipment. For procurement and engineering teams, IEEE 2621.3-2022 /UL 2621-3-2022 provides a focused reference for comparing solutions, documenting requirements, and managing risk in connected medical device designs.

• Wireless diabetes device security
• Mobile device control context
• Communication and access considerations
• Design, verification, and evaluation support
• Connected medical workflow consistency